The global electrophysiology mapping and ablation devices market is expected to witness rapid industrial growth in forthcoming years. The electrophysiology mapping and ablation devices have between each of them devised a definite approach to solving or treating inconsistent heart beats or irregular bio-rhythms which could have the potential of becoming very serious thus increasing chances of developing blood clots or the much more serious heart failure or even stroke.
Going ahead, a trial fibrillation (AFib) is the term used to denote irregular heartbeats and ablation is what doctors resort to get your breathing on an even scale. The noticeable symptoms of AFib are fatigue, shortness of breath and heart palpitations. All this could be very unsettling because these symptoms are life-threatening.
The drivers to growth of electrophysiology mapping and ablation devices market include the prevailing conditions such as flutter, a trial fibrillation that are upsetting the proper functioning of the heart. The recommended use of EP catheters in treatment of cardiovascular disorders is gaining persistent leverage which is forever blowing in the direction of electrophysiology study for heart. The percentage of success that catheters enjoy is boosting reputation of catheters and a studious patient reply to use of catheters in ablation procedure will tilt growth in favor of electrophysiology mapping and EP catheter ablation market, thus driving growth of electrophysiology mapping and ablation devices market.
The hospitals are slated to be the most prolific user of the EP Catheter and some pointers to Electrophysiology and EP catheters ablation market indicate that as this procedure requires extended stay at hospitals, growth for electrophysiology and ablation market should be quite high. An even observation to growth factors is that while ablation catheters in cardiac arrhythmia are quite high, a trial fibrillation will post high growth in electrophysiology mapping and ablation devices market.
North America will turn out as the largest market for EP catheter ablation with countries US and Canada reigning globally. The incidences of cardiovascular diseases on the rise and an underlying sound healthcare system will add to the growth of electrophysiology and ablation market. Asia Pacific will observe high growth in electrophysiology and catheter ablation devices industry on account of high growth in aging population and strong manufacturing market. Segmentation of Electrophysiology and catheter ablation devices industry by product includes diagnostic catheter, ablation catheter and lab devices and indication.
Diagnostic catheter includes conventional and ultrasound. Ablation catheter includes cryoablation, RF and microwave. Lab devices include mapping, recording, generator, ICE and X-ray. Indication includes AF, VT, WPW. The key industry players in the Electrophysiology and catheters and ablation devices industry include Medtronic Plc, Boston Scientific Corporation, Johnson and Johnson and Abbott Laboratories.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Electrophysiology Mapping and Ablation Devices in these regions, from 2012 to 2022 (forecast), covering
• North America
• Southeast Asia
Global Electrophysiology Mapping and Ablation Devices market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
• Arrow International Inc.
• AtriCure Inc.
• Biosense Webster Inc.
• Boston Scientific Corp.
• C.R. Bard Inc.
• Endosense SA
• Hansen Medical Inc.
• Medtronic Inc.
• St. Jude Medical Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
• Atrial Fibrillation
• Premature Ventricular Contractions (PVC)
• Atrial Flutter
• AV Re-entrant Tachycardia
• AV Nodal Tachycardia
Research Support Specialist, USA